首页 蛋白库 基因库 产品 会员服务
位置：首页 > 产品库 > TA-316
立即咨询
咨询类型：
     
*姓名：
*电话：
*单位：
Email：
*留言内容：
请详细说明您的需求。
*验证码：
 
TA-316
本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
TA-316图片
CAS NO:1429321-13-0
包装与价格：
包装价格(元)
5mg询价
10mg询价

TA-316 (Megakaryocytes/platelets inducing agent) 是一种新的化学合成的 c-MPL 激动剂 (CMA) 和血小板生成素 (TPO) 受体激动剂。TA-316 增强人诱导多能干细胞 (iPS) 血小板的生成。
Cas No.1429321-13-0
别名Megakaryocytes/platelets inducing agent
分子式C28H25BrN4O5S2
分子量641.56
溶解度DMSO : 50 mg/mL (77.94 mM; ultrasonic and warming and heat to 60°C)
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

TA-3166 (Megakaryocytes/platelets inducing agent) is a novel chemically synthesized c-MPL agonist (CMA) and thrombopoietin (TPO) receptor agonist. TA-316 enhances ex vivo platelet generation from human-induced pluripotent stem (iPS) cells[1][2].

TA-316 (0.01-1000 nM; 4 days) stimulates UT-7/TPO and Ba/F3-HuMpl cells proliferation, with the EC50 values of 0.3 and 0.65 nM, respectively[2].TA-316 (800 nM; 10 days) promotes biased megakaryopoiesis and upregulated MK lineage markers[2].TA-316 (200 nM; 4 days) preferentially enhances VEGFA and FGF2 expression[2].

[1]. METHOD FOR PRODUCING MEGAKARYOCYTES AND/OR PLATELETS FROM PLURIPOTENT STEM CELLS.WO2013051625A1.
[2]. Aihara A, et al. Novel TPO receptor agonist TA-316 contributes to platelet biogenesis from human iPS cells. Blood Adv. 2017;1(7):468-476. Published 2017 Feb 28.

 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2026